6
Participants
Start Date
October 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
EPTACOG BETA
"Eptacog beta (SEVENFACT®; EB) is a lyophilized powder in single-use vials (1, 2, or 5 mg) of coagulation factor VIIa (recombinant)-jncw. It is reconstituted with sterile water (provided in the kit) and administered intravenously.~SEVENFACT® may be administered by a healthcare provider (HCP) at the study site or home, or by a trained participant/caregiver. Participants will be monitored in a healthcare facility for 60 minutes after the first dose for hypersensitivity."
"Arthur M. Blank Hospital , Children's Healthcare of Atlanta"
Laboratoire Français du Fractionnement et des Biotechnologies (LFB BIOTECHNOLOGIES)
UNKNOWN
Emory University
OTHER